全部分类
  • MRTX9768 hydrochloride
MRTX9768 hydrochloride的可视化放大

MRTX9768 hydrochloride

MRTX9768 hydrochloride 是一种有效的,具有口服活性的 PRMT5 抑制剂。MRTX9768 hydrochloride可结合 PRMT5-MTA 复合体。

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

MRTX9768 hydrochloride的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 5mg
    ¥10250.00
    8200.00
    - +
  • 10mg
    ¥16025.00
    12820.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajcx34980
  • CAS: N/A
  • 别名:
  • 分子式: C24H18ClFN6O
  • 分子量: 460.89
  • 纯度: >98%
  • 溶解度: DMSO : 90 mg/mL (195.27 mM; Need ultrasonic)|Water : 40 mg/mL (86.79 mM; Need ultrasonic)
  • 储存: -20°C, protect from light
  • 库存: 现货

Background

MRTX9768 hydrochloride is a potent, orally active PRMT5 inhibitor. MRTX9768 hydrochloride is a synthetic lethal-based inhibitor binding the PRMT5-MTA complex[1].


MRTX9768 inhibits SDMA and cell proliferation in HCT116 MTAP-del cells (SDMA IC50 3 nM; prolif. IC50 11 nM) with marked selectivity over HCT116 MTAP-WT cells (SDMA IC50 544 nM; prolif. IC50 861 nM)[1].MRTX9768 selectively targets MTAP/CDKN2A-deleted tumors[2][1].


In xenograft studies, oral administration of MRTX9768 demonstrates dose-dependent inhibition of SDMA in MTAP-del tumors, with less SDMA modulation observed in bone marrow[1].


[1]. Christopher R. Smith, et al. Abstract LB003: Fragment based discovery of MRTX9768, a synthetic lethal-based inhibitor designed to bind the PRMT5-MTA complex and selectively target MTAP/CDKN2A-deleted tumors. AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA.
[2]. Yingqing Chen, et al. Targeting protein arginine methyltransferase 5 in cancers: Roles, inhibitors and mechanisms. Biomed Pharmacother. 2021 Oct 4;144:112252.

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算